AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy in Treating Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
- Status
- COMPLETED
- Phase
- PHASE1
PET/CT to Image Hypoxia in Head and Neck Tumours
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Head & Neck Cancer With Chemotherapy and Radiation
- Status
- COMPLETED
- Phase
- PHASE2
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
- Status
- COMPLETED
- Phase
- N/A
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Zalutumumab in Patients With Non-curable Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Zinc Supplements in Lowering Cadmium Levels in Smokers
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
- Status
- WITHDRAWN
- Phase
- NA